Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,953 public trials 458 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Recruiting

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

NCT06782490

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +13 more
Locations
  • Alabama Neurology Associates Birmingham, Alabama, United States
  • Perseverance Research Center,LLC Scottsdale, Arizona, United States
  • Local Institution - 0017 Aurora, Colorado, United States
  • Aqualane Clinical Research Naples, Florida, United States
View all 55 locations
View Trial Details
Recruiting

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

NCT07067463

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Arizona Neuroscience Research, LLC Pheonix, Arizona, United States
  • Perseverance Research Center Scottsdale, Arizona, United States
  • Regina Berkovich MD, PhD Inc. West Hollywood, California, United States
  • Nova Clinical Research, LLC Bradenton, Florida, United States
View all 47 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

NCT06858579

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Clinical Study Site Birmingham, Alabama, United States
  • Clinical Study Site Phoenix, Arizona, United States
  • Clinical Study Site Scottsdale, Arizona, United States
  • Clinical Study Site Los Angeles, California, United States
View all 188 locations
View Trial Details
Recruiting

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

NCT07299019

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Arizona Neuroscience Research, LLC Phoenix, Arizona, United States
  • Perseverance Research Center, LLC (PRC) Scottsdale, Arizona, United States
  • Fullerton Neurology and Headache Center Fullerton, California, United States
  • Regina Berkovich MD, PhD Inc West Hollywood, California, United States
View all 34 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)

NCT07282574

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Southern Neurology Kogarah, New South Wales, Australia
  • John Hunter Hospital New Lambton Heights, New South Wales, Australia
  • Box Hill Hospital Box Hill, Victoria, Australia
  • Austin Health Heidelberg, Victoria, Australia
View all 108 locations
View Trial Details

Related conditions